Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Video Credit: Wochit Tech
Published on October 22, 2020 - Duration: 00:32s

Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19.

Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday.

The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis.

The medication is an immunosuppressive drug designed to reduce inflammation.


You are here

Related videos from verified sources

Cognitive disorders linked to severe COVID-19 risk, suggests study 01:23
Video credit: ANI - Published on October 29, 2020 

Flu Vaccine May Lower Risk Of Severe Illness From COVID-19 00:32
Video credit: Wochit - Published on October 29, 2020 

Study Finds Taking Aspirin Significantly Lowers Risk Of Complications, Death In Coronavirus Patients 02:11
Video credit: WJZ Baltimore - Published on October 23, 2020 

You might like